Delivery Order SPE2DX22D0049-SPE2D826FA4BL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,908.34 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract, which is non-set-aside and competitively awarded, operates under a firm fixed-price arrangement with an ultimate completion date of January 13, 2026. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,561.40 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of January 30, 2026, represents a child contract under AmerisourceBergen's parent company, Cencora, Inc. The award was made on a competitive basis with no set-aside designation, consistent with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $49,815.06 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, which carries an ultimate completion date of January 20, 2026, represents a child contract under the parent organization Cencora, Inc. (doing business as AmerisourceBergen). The award was made on a competitive, non-set-aside basis and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,018.18 on February 2, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract carries a firm fixed-price structure with an ultimate completion date of February 3, 2026, and represents a non-set-aside competitive award. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $178,629.90 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, has an ultimate completion date of January 20, 2026. The contract was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's established...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $49,902.34 by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation, reflecting the contractor's ability to compete on a full and open basis for federal procurement requirements. The delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $898,115.55 on January 24, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen serves as a critical supplier of pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,090.60 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on January 13, 2026. The award represents a child task order under AmerisourceBergen's parent company Cencora, Inc., which holds a substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-competitive delivery order is expected to be completed by November 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA4BLDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,895.90 on February 2, 2026, with an ultimate completion date of February 3, 2026. This competitively awarded, firm fixed-price contract was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. The contract represents a non-set-aside award, indicating that AmerisourceBergen competed on a full and open basis against other qualified vendors. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The parent company, Cencora, Inc., which does business as AmerisourceBergen, maintains this substantial contract vehicle and holds a comparable $999,999,999.00 IDC with DLA Troop Support Medical through December 31, 2031, demonstrating the company's critical role in federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 2/1/26 |